Third Rock Ventures II, L.P.
10% owner at MyoKardia Inc; 10% owner at Global Blood Therapeutics, Inc.
- Sold, on record
- $47.9M
- Dollars the filings state
- Form 4 sales
- 2
- Latest Sep 11, 2017
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- MyoKardia Inc10% owner
- Global Blood Therapeutics, Inc.10% owner
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Sales by company
- Global Blood Therapeutics, Inc.2M shares
- MyoKardia Inc221,250 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Global Blood Therapeutics, Inc.UnusualNov 14, 2016 2016
Sold 2M shares at $19.36 ($38.7M)
Third Rock Ventures II, L.P., 10% owner
Sold 60.9% of holdings ($63.6M position)1.3M shares leftFirst sale on recordFiling
- 2 Form 4 sale MyoKardia IncUnusualSep 11, 2017 +301 days
Sold 221,250 shares at $41.30 ($9.1M)
Third Rock Ventures II, L.P., 10% owner
Sold 79.3% of holdings ($11.5M position)57,651 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (2)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2017 | Sep 12, 2017 | MyoKardia Inc | 10% owner | Form 4 sale | 221,250 | $9.1M | 79.3% | Unusual | SEC |
| Nov 14, 2016 | Nov 16, 2016 | Global Blood Therapeutics, Inc. | 10% owner | Form 4 sale | 2M | $38.7M | 60.9% | Unusual | SEC |